SENSEX
NIFTY
GOLD
USD/INR

Weather

image 7    C

Business News

The Hindu Businessline

Business / The Hindu Businessline

details

Pharma stocks in focus: Why Cipla, Zydus and Biocon matter on Friday

Cipla flagged temporary supply constraints for Lanreotide, Zydus won final USFDA approval for a blood-disorder drug, while Biocon strengthened its balance sheet via a Rs 4,150-crore QIP.

16 Jan 2026 7:21 am